Thomas Bush - BIO Key Director
| BKYI Stock | USD 1.68 0.02 1.18% |
Director
Mr. Thomas E. Bush, III is a Director of BIOkey International, Inc. Thomas E. Bush, III, served with the Federal Bureau of Investigation for over 33 years. Bush joined the FBI on September 8, 1975. Early in his FBI career, he worked in the Identification Division and Information Resources Division. During his 33 year career as a Special Agent he rose through the ranks of the FBI ultimately becoming the Director of the CJIS division. During Bush tenure with the CJIS division he was responsible for the day to day operation of the largest division of the FBI, with over 2, 500 employees and a budget of approximately one billion dollars. Known for providing critical services in support of the criminal justice community, two significant IT projects, Next Generation Identification and NDex, were awarded by CJIS with early increments delivered during his tenure. He was the recipient of many awards during his tenure, most notably a Presidential Rank Award for Meritorious Service in 2007. since 2014.
| Age | 62 |
| Tenure | 10 years |
| Address | Building A, Wall, NJ, United States, 07719 |
| Phone | 732 359 1100 |
| Web | https://www.bio-key.com |
BIO Key Management Efficiency
The company has return on total asset (ROA) of (0.273) % which means that it has lost $0.273 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2593) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1. The BIO Key's current Return On Capital Employed is estimated to increase to -1.46. As of now, BIO Key's Net Tangible Assets are increasing as compared to previous years. The BIO Key's current Intangibles To Total Assets is estimated to increase to 0.17, while Total Assets are projected to decrease to under 10.2 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Bridgette Heller | ADT Inc | 53 | |
| Anne Mariucci | CoreCivic | 63 | |
| Donna Alvarado | CoreCivic | 72 | |
| Charles Jacobi | CoreCivic | 73 | |
| Gregory Omi | Iveda Solutions | 63 | |
| Manuel Stamatakis | Mistras Group | 75 | |
| John Harper | NL Industries | 59 | |
| Dusan Lukic | ADT Inc | N/A | |
| Matthew Nord | ADT Inc | 41 | |
| Nicholas DeBenedictis | Mistras Group | 75 | |
| Richard Daly | ADT Inc | 61 | |
| Lee Solomon | ADT Inc | 48 | |
| Tracey Griffin | ADT Inc | 55 | |
| Christopher Kingsman | ADT Inc | N/A | |
| John Swaite | ADT Inc | N/A | |
| ChenHo Kuo | Iveda Solutions | 52 | |
| Robert Gillen | Iveda Solutions | 60 | |
| Keith Coogan | NL Industries | 64 | |
| Joseph Russell | CoreCivic | 73 | |
| C Jacobi | CoreCivic | 73 | |
| John Prann | CoreCivic | 70 | |
Management Performance
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.27 |
BIO Key International Leadership Team
Elected by the shareholders, the BIO Key's board of directors comprises two types of representatives: BIO Key inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIO. The board's role is to monitor BIO Key's management team and ensure that shareholders' interests are well served. BIO Key's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIO Key's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Mahnken, VP of Marketing | ||
| Mark Cochran, President PortalGuard | ||
| Cecilia Welch, Chief Officer | ||
| Pieter Knook, Director | ||
| Akintunde Jeje, Managing Africa | ||
| Alex Rocha, Managing EMEA | ||
| Thomas Gilley, Director | ||
| Kwok Wong, MD ViceChairman | ||
| Michael DePasquale, Chairman, CEO and Pres | ||
| Frederick Corsentino, Chief Revenue Officer | ||
| Jianhui Yau, Director | ||
| James Sullivan, Senior Officer | ||
| Thomas Bush, Director | ||
| Fabian Shin, Director | ||
| Robert Michel, Director | ||
| Mira LaCous, Chief Officer | ||
| Charles Romeo, Independent Director | ||
| John Schoenherr, Independent Director | ||
| Barbara Rivera, Director | ||
| Renat Zhdanov, Chief Scientist and VP |
BIO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BIO Key a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (1.06) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 3.83 M | ||||
| Shares Outstanding | 1.81 M | ||||
| Shares Owned By Insiders | 4.90 % | ||||
| Shares Owned By Institutions | 5.40 % | ||||
| Number Of Shares Shorted | 18.84 K | ||||
| Price To Earning | (2.55) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BIO Key in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BIO Key's short interest history, or implied volatility extrapolated from BIO Key options trading.
Pair Trading with BIO Key
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIO Key position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIO Key will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to BIO Key could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIO Key when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIO Key - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIO Key International to buy it.
The correlation of BIO Key is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIO Key moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIO Key International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BIO Key can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is BIO Key's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.62) | Revenue Per Share 17.484 | Quarterly Revenue Growth 0.323 | Return On Assets (0.27) | Return On Equity (1.26) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.